New therapeutic approach may help treat age-related macular degeneration effectively (IMAGE)
Caption
: RUNX1 inhibition combined with anti-vascular endothelial growth factor (anti-VEGF) therapy achieves better control of experimental choroidal neovascularization activity compared to monotherapy.
Credit
The American Journal of Pathology
Usage Restrictions
None
License
Licensed content